Review



‒ anti cd137 pe vio 615  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Miltenyi Biotec ‒ anti cd137 pe vio 615
    ‒ Anti Cd137 Pe Vio 615, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 122 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd137+pe/CD4+Antibody%2C+anti-mouse%2C+REAfinity/pm42098128-440-36-41
    Average 95 stars, based on 122 article reviews
    ‒ anti cd137 pe vio 615 - by Bioz Stars, 2026-09
    95/100 stars

    Images

    Related Articles

    Staining:

    Article Title: TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs.
    Article Snippet: .. After 6 hours, cells were harvested from the plate, washed with PBS, and stained with the following antibody cocktail at the respective concentration: Live/dead APC at 1/200 (#L10102, Invitrogen, Thermo Fisher Scientific), CD4 Pacific Blue at 1/33 (RRID:AB 397037, #558116, BD Biosciences), CD8 FITC at 1/200 (RRID:AB 1877178, #344704, BioLegend), CD137 PE at 1/20 (RRID:AB 2654986, #130-110-763, Miltenyi Biotec). ..

    Article Title: Immunogenic properties of nickel-doped maghemite nanoparticles and the implication for cancer immunotherapy
    Article Snippet: .. The cells were stained with CD3-PerCP-Cy5.5 (eBiosciences), CD4-PE-Cy7, CD8-Alexa Fluor 700, Ki-67-APC (Exbio), and CD137-PE (Miltenyi Biotec). ..

    Concentration Assay:

    Article Title: TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs.
    Article Snippet: .. After 6 hours, cells were harvested from the plate, washed with PBS, and stained with the following antibody cocktail at the respective concentration: Live/dead APC at 1/200 (#L10102, Invitrogen, Thermo Fisher Scientific), CD4 Pacific Blue at 1/33 (RRID:AB 397037, #558116, BD Biosciences), CD8 FITC at 1/200 (RRID:AB 1877178, #344704, BioLegend), CD137 PE at 1/20 (RRID:AB 2654986, #130-110-763, Miltenyi Biotec). ..

    Activation Assay:

    Article Title: Non-viral delivery of RNA for therapeutic T cell engineering.
    Article Snippet: .. To analyze the activation status of T cells pre-treated by PEN photoporation and stimulated with ImmunoCult Activator for 48 h, the following anti-human monoclonal antibodies were used: CD25 FITC, CD69 FITC, CD154 FITC, CD137 PE, HLA-DR PerCP/Cy5, PD-1 FITC (all from BioLegend, USA) and PD-1 PE (Miltenyi Biotec, Germany). ..

    Bioprocessing:

    Article Title: Non-viral delivery of RNA for therapeutic T cell engineering.
    Article Snippet: .. To analyze the activation status of T cells pre-treated by PEN photoporation and stimulated with ImmunoCult Activator for 48 h, the following anti-human monoclonal antibodies were used: CD25 FITC, CD69 FITC, CD154 FITC, CD137 PE, HLA-DR PerCP/Cy5, PD-1 FITC (all from BioLegend, USA) and PD-1 PE (Miltenyi Biotec, Germany). ..

    other:

    Article Title: A therapeutic regimen using neoantigen-specific TCR-T cells for HLA-A*2402-positive solid tumors
    Article Snippet: CD137-PE , Miltenyi Biotec , Cat no. 130-119-885.

    Labeling:

    Article Title: Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study.
    Article Snippet: We adapted the assay from the originally described antigenreactive T-cell enrichment procedure17 and activation-induced marker assay.18,19 In brief, ~0.5 × 107 to 4 × 107 cryopreserved PBMCs were plated in RPMI 1640 medium (Gibco), supplemented with 5% human AB serum (Sigma Aldrich, Schnelldorf, Germany), and stimulated with GPIIb/IIIa peptides or dimethyl sulfoxide alone for 24 hours in the presence of 1 mg/mL CD40 and 1 mg/ mL CD28 pure antibody (both from Miltenyi Biotec, Bergisch Gladbach, Germany). .. Cells were labeled with CD154-biotin and CD137-PE, and anti-biotin (CD154 MicroBead Kit, Miltenyi Biotec) and anti-PE (CD137 MicroBead Kit, Miltenyi Biotec) antibodies were added, then were magnetically enriched by using MS Columns (Miltenyi Biotec). ..



    Similar Products

    95
    Miltenyi Biotec ‒ anti cd137 pe vio 615
    ‒ Anti Cd137 Pe Vio 615, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd137+pe/CD4+Antibody%2C+anti-mouse%2C+REAfinity/pm42098128-440-36-41
    Average 95 stars, based on 1 article reviews
    ‒ anti cd137 pe vio 615 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec anti human cd137 pe
    Anti Human Cd137 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd137+pe/CD137+Antibody%2C+anti-human/bio_rxiv__64898__2026__03__16__711991-163-44-47
    Average 93 stars, based on 1 article reviews
    anti human cd137 pe - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    85
    R&D Systems cd137
    Cd137, supplied by R&D Systems, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd137+pe/Mouse+4-1BB%2FTNFRSF9%2FCD137+PE-conjugated+Antibody/us12558375-1060-12-30
    Average 85 stars, based on 1 article reviews
    cd137 - by Bioz Stars, 2026-09
    85/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec anti cd137 pe
    Anti Cd137 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd137+pe/CD137+Antibody%2C+anti-human%2C+REAfinity/pmc12956582-218-131-134
    Average 94 stars, based on 1 article reviews
    anti cd137 pe - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec staining with cd137
    CAR-T cells targeting the MICB-derived octapeptide show CAR-dependent activation and efficiently kill tumor cells (A) Schematic representation of scFv of both 8-VHVL CAR and 8-VLVH CAR targeting the octapeptide VLQSQRTD used in this study. (B) Expression of CAR molecules on T cells. Left panel shows representative plots of flow cytometry data of primary T cells, 8-VHVL CAR-T and 8-VLVH CAR-T. Right panel shows expression of both experimental CARs (8-VHVL and 8-VLVH) as well as CD4 and CD19 CAR on T cells. Black bars represent CAR expression detected via anti-mouse F(abʹ) 2 antibody, and green bars represent EGFP signal; data from n = 18 independent experiments are depicted as mean (SEM). (C) CAR-T cells were cocultured with Mac-1 cells stably transduced to express indicated transgenes. Tumor cells were labeled with CellTrace Violet, and killing was assessed via PI staining. Killing is depicted as ratio of PI+ cells in cocultures and independently cultured Mac-1 cells. Data from n ≥ 6 experiments are depicted as mean (SEM). (D) <t>CD137</t> expression was measured on CAR-T cells after incubation with Mac-1 for 24 h. Data are shown from EGFP+ CAR-T cells and are depicted from n = 6 independent experiments as mean (SEM). (E) CAR-T cells were cocultured with T cells from the same donor transduced to express indicated transgenes. T cells used as target cells were labeled with CellTrace Violet, and killing was assessed via PI staining. Only EGFP+ target T cells were analyzed for PI staining. Killing is depicted as the ratio of PI+ cells in cocultures and independently cultured target T cells. Data from n = 9 independent experiments are shown as mean (SEM). (F) CD137 expression was measured on CAR-T cells after incubation with transduced T cells as target cells for 24 h. Data are shown from EGFP+ CAR-T cells and are depicted from n = 6 independent experiments as mean (SEM). (G) LAG-3 expression was measured on CAR-T cells after incubation with transduced T cells as target cells for 72 h. Data are shown from EGFP+ CAR-T cells from n = 4 experiments as mean (SEM); statistical analysis of (C) through (G) was performed by two-way ANOVA followed by Dunnett’s multiple-comparisons test, and experimental groups were compared to CD19 CAR. ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, and ∗∗∗∗ = p ≤ 0.0001.
    Staining With Cd137, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd137+pe/CD137+Antibody%2C+anti-human%2C+PE-Vio+770%2C+REAfinity/pmc12495166-412-6-14
    Average 94 stars, based on 1 article reviews
    staining with cd137 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec cd137 antibody, anti-human
    CAR-T cells targeting the MICB-derived octapeptide show CAR-dependent activation and efficiently kill tumor cells (A) Schematic representation of scFv of both 8-VHVL CAR and 8-VLVH CAR targeting the octapeptide VLQSQRTD used in this study. (B) Expression of CAR molecules on T cells. Left panel shows representative plots of flow cytometry data of primary T cells, 8-VHVL CAR-T and 8-VLVH CAR-T. Right panel shows expression of both experimental CARs (8-VHVL and 8-VLVH) as well as CD4 and CD19 CAR on T cells. Black bars represent CAR expression detected via anti-mouse F(abʹ) 2 antibody, and green bars represent EGFP signal; data from n = 18 independent experiments are depicted as mean (SEM). (C) CAR-T cells were cocultured with Mac-1 cells stably transduced to express indicated transgenes. Tumor cells were labeled with CellTrace Violet, and killing was assessed via PI staining. Killing is depicted as ratio of PI+ cells in cocultures and independently cultured Mac-1 cells. Data from n ≥ 6 experiments are depicted as mean (SEM). (D) <t>CD137</t> expression was measured on CAR-T cells after incubation with Mac-1 for 24 h. Data are shown from EGFP+ CAR-T cells and are depicted from n = 6 independent experiments as mean (SEM). (E) CAR-T cells were cocultured with T cells from the same donor transduced to express indicated transgenes. T cells used as target cells were labeled with CellTrace Violet, and killing was assessed via PI staining. Only EGFP+ target T cells were analyzed for PI staining. Killing is depicted as the ratio of PI+ cells in cocultures and independently cultured target T cells. Data from n = 9 independent experiments are shown as mean (SEM). (F) CD137 expression was measured on CAR-T cells after incubation with transduced T cells as target cells for 24 h. Data are shown from EGFP+ CAR-T cells and are depicted from n = 6 independent experiments as mean (SEM). (G) LAG-3 expression was measured on CAR-T cells after incubation with transduced T cells as target cells for 72 h. Data are shown from EGFP+ CAR-T cells from n = 4 experiments as mean (SEM); statistical analysis of (C) through (G) was performed by two-way ANOVA followed by Dunnett’s multiple-comparisons test, and experimental groups were compared to CD19 CAR. ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, and ∗∗∗∗ = p ≤ 0.0001.
    Cd137 Antibody, Anti Human, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd137+pe/CD137+Antibody%2C+anti-human/custom%40130-119-971%4041401806
    Average 93 stars, based on 1 article reviews
    cd137 antibody, anti-human - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec cd137 antibody
    CAR-T cells targeting the MICB-derived octapeptide show CAR-dependent activation and efficiently kill tumor cells (A) Schematic representation of scFv of both 8-VHVL CAR and 8-VLVH CAR targeting the octapeptide VLQSQRTD used in this study. (B) Expression of CAR molecules on T cells. Left panel shows representative plots of flow cytometry data of primary T cells, 8-VHVL CAR-T and 8-VLVH CAR-T. Right panel shows expression of both experimental CARs (8-VHVL and 8-VLVH) as well as CD4 and CD19 CAR on T cells. Black bars represent CAR expression detected via anti-mouse F(abʹ) 2 antibody, and green bars represent EGFP signal; data from n = 18 independent experiments are depicted as mean (SEM). (C) CAR-T cells were cocultured with Mac-1 cells stably transduced to express indicated transgenes. Tumor cells were labeled with CellTrace Violet, and killing was assessed via PI staining. Killing is depicted as ratio of PI+ cells in cocultures and independently cultured Mac-1 cells. Data from n ≥ 6 experiments are depicted as mean (SEM). (D) <t>CD137</t> expression was measured on CAR-T cells after incubation with Mac-1 for 24 h. Data are shown from EGFP+ CAR-T cells and are depicted from n = 6 independent experiments as mean (SEM). (E) CAR-T cells were cocultured with T cells from the same donor transduced to express indicated transgenes. T cells used as target cells were labeled with CellTrace Violet, and killing was assessed via PI staining. Only EGFP+ target T cells were analyzed for PI staining. Killing is depicted as the ratio of PI+ cells in cocultures and independently cultured target T cells. Data from n = 9 independent experiments are shown as mean (SEM). (F) CD137 expression was measured on CAR-T cells after incubation with transduced T cells as target cells for 24 h. Data are shown from EGFP+ CAR-T cells and are depicted from n = 6 independent experiments as mean (SEM). (G) LAG-3 expression was measured on CAR-T cells after incubation with transduced T cells as target cells for 72 h. Data are shown from EGFP+ CAR-T cells from n = 4 experiments as mean (SEM); statistical analysis of (C) through (G) was performed by two-way ANOVA followed by Dunnett’s multiple-comparisons test, and experimental groups were compared to CD19 CAR. ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, and ∗∗∗∗ = p ≤ 0.0001.
    Cd137 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd137+pe/CD137+Antibody%2C+anti-mouse%2C+PE/pmc12219838-397-6-8
    Average 93 stars, based on 1 article reviews
    cd137 antibody - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    CAR-T cells targeting the MICB-derived octapeptide show CAR-dependent activation and efficiently kill tumor cells (A) Schematic representation of scFv of both 8-VHVL CAR and 8-VLVH CAR targeting the octapeptide VLQSQRTD used in this study. (B) Expression of CAR molecules on T cells. Left panel shows representative plots of flow cytometry data of primary T cells, 8-VHVL CAR-T and 8-VLVH CAR-T. Right panel shows expression of both experimental CARs (8-VHVL and 8-VLVH) as well as CD4 and CD19 CAR on T cells. Black bars represent CAR expression detected via anti-mouse F(abʹ) 2 antibody, and green bars represent EGFP signal; data from n = 18 independent experiments are depicted as mean (SEM). (C) CAR-T cells were cocultured with Mac-1 cells stably transduced to express indicated transgenes. Tumor cells were labeled with CellTrace Violet, and killing was assessed via PI staining. Killing is depicted as ratio of PI+ cells in cocultures and independently cultured Mac-1 cells. Data from n ≥ 6 experiments are depicted as mean (SEM). (D) CD137 expression was measured on CAR-T cells after incubation with Mac-1 for 24 h. Data are shown from EGFP+ CAR-T cells and are depicted from n = 6 independent experiments as mean (SEM). (E) CAR-T cells were cocultured with T cells from the same donor transduced to express indicated transgenes. T cells used as target cells were labeled with CellTrace Violet, and killing was assessed via PI staining. Only EGFP+ target T cells were analyzed for PI staining. Killing is depicted as the ratio of PI+ cells in cocultures and independently cultured target T cells. Data from n = 9 independent experiments are shown as mean (SEM). (F) CD137 expression was measured on CAR-T cells after incubation with transduced T cells as target cells for 24 h. Data are shown from EGFP+ CAR-T cells and are depicted from n = 6 independent experiments as mean (SEM). (G) LAG-3 expression was measured on CAR-T cells after incubation with transduced T cells as target cells for 72 h. Data are shown from EGFP+ CAR-T cells from n = 4 experiments as mean (SEM); statistical analysis of (C) through (G) was performed by two-way ANOVA followed by Dunnett’s multiple-comparisons test, and experimental groups were compared to CD19 CAR. ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, and ∗∗∗∗ = p ≤ 0.0001.

    Journal: Molecular Therapy Oncology

    Article Title: Enhanced solid tumor cell targeting by a neoepitope-encoding oncolytic measles virus combined with CAR therapy

    doi: 10.1016/j.omton.2025.201043

    Figure Lengend Snippet: CAR-T cells targeting the MICB-derived octapeptide show CAR-dependent activation and efficiently kill tumor cells (A) Schematic representation of scFv of both 8-VHVL CAR and 8-VLVH CAR targeting the octapeptide VLQSQRTD used in this study. (B) Expression of CAR molecules on T cells. Left panel shows representative plots of flow cytometry data of primary T cells, 8-VHVL CAR-T and 8-VLVH CAR-T. Right panel shows expression of both experimental CARs (8-VHVL and 8-VLVH) as well as CD4 and CD19 CAR on T cells. Black bars represent CAR expression detected via anti-mouse F(abʹ) 2 antibody, and green bars represent EGFP signal; data from n = 18 independent experiments are depicted as mean (SEM). (C) CAR-T cells were cocultured with Mac-1 cells stably transduced to express indicated transgenes. Tumor cells were labeled with CellTrace Violet, and killing was assessed via PI staining. Killing is depicted as ratio of PI+ cells in cocultures and independently cultured Mac-1 cells. Data from n ≥ 6 experiments are depicted as mean (SEM). (D) CD137 expression was measured on CAR-T cells after incubation with Mac-1 for 24 h. Data are shown from EGFP+ CAR-T cells and are depicted from n = 6 independent experiments as mean (SEM). (E) CAR-T cells were cocultured with T cells from the same donor transduced to express indicated transgenes. T cells used as target cells were labeled with CellTrace Violet, and killing was assessed via PI staining. Only EGFP+ target T cells were analyzed for PI staining. Killing is depicted as the ratio of PI+ cells in cocultures and independently cultured target T cells. Data from n = 9 independent experiments are shown as mean (SEM). (F) CD137 expression was measured on CAR-T cells after incubation with transduced T cells as target cells for 24 h. Data are shown from EGFP+ CAR-T cells and are depicted from n = 6 independent experiments as mean (SEM). (G) LAG-3 expression was measured on CAR-T cells after incubation with transduced T cells as target cells for 72 h. Data are shown from EGFP+ CAR-T cells from n = 4 experiments as mean (SEM); statistical analysis of (C) through (G) was performed by two-way ANOVA followed by Dunnett’s multiple-comparisons test, and experimental groups were compared to CD19 CAR. ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, and ∗∗∗∗ = p ≤ 0.0001.

    Article Snippet: For evaluation of CAR-T cell activation, staining with CD137 (CD137 Antibody, PE-Vio770, anti-human, REAfinity) (Miltenyi Biotech, Bergisch Gladbach, Germany) was carried out after 24 h of co-incubation.

    Techniques: Derivative Assay, Activation Assay, Expressing, Flow Cytometry, Stable Transfection, Labeling, Staining, Cell Culture, Incubation